Sale to further reduce capital intensity and exposure to interest rates Reduced sensitivity to interest rates reduces capital required to protect against volatility Transaction adds 8 percentage points to Swiss Solvency Test ratio1 Zurich in Germany to continue to invest … Read the full press release
Venta para reducir aún más la intensidad de capital y la exposición a tipos de interés La sensibilidad reducida a las tasas de interés reduce el capital requerido para protegerse contra la volatilidad La transacción agrega 8 puntos porcentuales al … Read the full press release
Transaction to release approximately USD 1.2 billion of capital and add 11 percentage points to the Group’s Swiss Solvency Test ratio1 Significant reduction in the Group’s exposure to credit risk Zurich will focus on protection and unit-linked solutions in the … Read the full press release
Posted in Business, Financial, Insurance, News, Portugal, Switzerland
Tagged acquisition, Deutsche Bank, GamaLife, George Quinn, insurance, life insurance, Matteo Castelvetri, pension back book, pension market, policyholders, Swiss Solvency Test, Zurich, Zurich Insurance Group, Zurich Investments Life S.p.A.
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
